Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Abbott has launched Above the Bias, a global initiative to drive awareness about the health impact that common misconceptions and bias about diabetes can have on people living with ...

The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ ...

The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ 15.05 billion in 2024 and an impressive US$ 22.63 billion ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

It induces the cells to absorb glucose from the food people eat. Insulin usually helps the body maintain a good balance of energy by preventing the level of blood glucose from spiking for too long.

High blood sugar, also known as hyperglycemia, is a serious health condition that is marked by the excessive presence of glucose and lack of insulin in the body. This condition is extremely common ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a ...

(Reuters) - Abbott Laboratories (NYSE:ABT) on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose ...

Abbott Banks on Glucose Monitors, New Launches to Ride Out China, Currency Hit By Christy Santhosh and Puyaan Singh (Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in ...